lymphocytes, tumor-infiltrating

Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer
Kelly Boelaars, Laura Goossens-Kruijssen, Di Wang, Charlotte M de Winde, Ernesto Rodriguez, Dimitri Lindijer, Babet Springer, Irene van der Haar Àvila, Aram de Haas, Laetitia Wehry, Louis Boon, Reina E Mebius, Nadine van Montfoort, Manfred Wuhrer, Joke M M den Haan, Sandra J van Vliet, Yvette van Kooyk

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007805; DOI: 10.1136/jitc-2023-007805
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers
Kensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, Xiao Yang, Zachary Conrad Hartman, Amy Hobeika, Philip F Hughes, Timothy A J Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004793; DOI: 10.1136/jitc-2022-004793
Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy
Dayana Blokon-Kogan, Maya Levi-Mann, Lior Malka-Levy, Orit Itzhaki, Michal J Besser, Yuval Shiftan, Árpád Szöőr, György Vereb, Gideon Gross, Hinrich Abken, Hadas Weinstein-Marom

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e001544; DOI: 10.1136/jitc-2020-001544
Novel peptide-based vaccine targeting heat shock protein 90 induces effective antitumor immunity in a HER2+ breast cancer murine model
Jinho Kang, Hye-Jin Lee, Jimin Lee, Jinhwa Hong, Yeul Hong Kim, Mary L Disis, Jeong-An Gim, Kyong Hwa Park

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004702; DOI: 10.1136/jitc-2022-004702
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette Leusen, Mikaela Grönholm, Vincenzo Cerullo

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (3) e008342; DOI: 10.1136/jitc-2023-008342
Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer
Yibo Quan, Jie He, Qi Zou, Liuxi Zhang, Qihui Sun, Hongli Huang, Wanglin Li, Keping Xie, Fang Wei

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007080; DOI: 10.1136/jitc-2023-007080
Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade
Minglei Wang, Yiheng Huang, Minxin Chen, Weiyan Wang, Fei Wu, Tao Zhong, Xiaozheng Chen, Fei Wang, Yang Li, Jinming Yu, Meng Wu, Dawei Chen

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007035; DOI: 10.1136/jitc-2023-007035
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
Veronica Finisguerra, Tereza Dvorakova, Matteo Formenti, Pierre Van Meerbeeck, Lionel Mignion, Bernard Gallez, Benoit J Van den Eynde

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e005719; DOI: 10.1136/jitc-2022-005719
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
Luc Magré, Monique M A Verstegen, Sonja Buschow, Luc J W van der Laan, Maikel Peppelenbosch, Jyaysi Desai

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006290; DOI: 10.1136/jitc-2022-006290
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Clémence Demerlé, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frédéric Fiore, Jacques A Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Hervé Luche, Fabrice Barlesi, Daniel Olive

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006348; DOI: 10.1136/jitc-2022-006348

Main menu

lymphocytes, tumor-infiltrating

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

lymphocytes, tumor-infiltrating

Pages